Description
Cell line name NCC-LMS2-C1
Accession CVCL_A4EE
Resource Identification Initiative To cite this cell line use: NCC-LMS2-C1 (RRID:CVCL_A4EE)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 46 hours (PubMed=33001379).
Derived from site: Metastatic; Thigh; UBERON=UBERON_0000376.
Disease Leiomyosarcoma (NCIt: C3158)
Leiomyosarcoma (ORDO: Orphanet_64720)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 90Y
Category Cancer cell line
STR profile
Source(s): PubMed=33001379
Markers:
Amelogenin | X |
CSF1PO | 11 |
D5S818 | 13 |
D7S820 | 12 |
D13S317 | 11,13 |
D16S539 | 9 |
D21S11 | 29 |
TH01 | 9 |
TPOX | 8,11 |
vWA | 17 |
Publications
PubMed=33001379; DOI=10.1007/s13577-020-00443-6
Noguchi R., Yoshimatsu Y., Ono T., Sei A., Hirabayashi K., Ozawa I., Kikuta K., Kondo T.
Establishment and characterization of NCC-LMS2-C1-a novel patient-derived cancer cell line of leiomyosarcoma.
Hum. Cell 34:279-288(2021)
Cross-references
Encyclopedic resources Wikidata; Q105510289
Reviews
There are no reviews yet.